Several Lines of evidence, including newly discovered genetic mutation
s, suggest that beta-amyloid (A beta) is directly involved in the neur
opathology observed in familial and sporadic forms of Alzheimer's dise
ase (AD). Rather than exerting its neurotoxicity directly, results fro
m our Laboratory suggest that fibrillar A beta (fA beta) activates mic
roglia and astrocytes upon injection into the rat brain. The microglia
and astrocytes, in turn, form a functional barrier between A beta and
surrounding neurons. An increase in inducible nitric oxide synthase (
iNOS) immunoreactivity is observed in activated microglia and astrocyt
es, and specific subpopulations of neurons are lost in fA beta injecti
on areas versus controls. These data, coupled with recent discoveries
of the A beta association with the receptor for advanced glycation end
products (RAGE) and the class A scavenger receptors (SR), support the
hypothesized sized role of inflammatory mechanisms in AD neurotoxicit
y.